User menu

Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe.

Bibliographic reference Boer, K ; England, K ; Godfried, M H ; Thorne, C ; Brichard, Bénédicte. Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe.. In: HIV medicine, Vol. 11, no.6, p. 368-78 (2010)
Permanent URL http://hdl.handle.net/2078.1/125174
  1. 1  Boer K , Nellen JF , Patel D et al. The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery. BJOG 2007; 114: 148–155.
  2. 2 European Collaborative Study. The mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the West. AIDS 2006; 20: 1419–1427.
  3. 3  Townsend CL , Cortina-Borja M , Peckham CS , de RA , Lyall H , Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006. AIDS 2008; 22: 973–981.
  4. 4  Warszawski J , Tubiana R , Le CJ et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008; 22: 289–299.
  5. 5 European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994; 343: 1464–1467.
  6. 6  Villari P , Spino C , Chalmers TC , Lau J , Sacks HS. Cesarean section to reduce perinatal transmission of human immunodeficiency virus. A metaanalysis. Online J Curr Clin Trials 1993; (Doc No 74): 5107.
  7. 7  Mandelbrot L , Le CJ , Berrebi A et al. Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA 1998; 280: 55–60.
  8. 8 European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999; 353: 1035–1039.
  9. 9 International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 – a meta-analysis of 15 prospective cohort studies. N Engl J Med 1999; 340: 977–987.
  10. 10  Connor EM , Sperling RS , Gelber R et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331: 1173–1180.
  11. 11  Sperling RS , Shapiro DE , Coombs RW et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1996; 335: 1621–1629.
  12. 12 European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40: 458–465.
  13. 13 Werkgroep Antiretrovirale. Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van AIDS Behandelaren [Revised guidelines “Antiretroviral Treatment”]. Ned Tijdschr Geneeskd 2005; 149: 2399–2405.
  14. 14  Burdge DR , Money DM , Forbes JC et al. Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines). CMAJ 2003; 168: 1671–1674.
  15. 15  Buchholz B , Beichert M , Marcus U et al. German-Austrian recommendations for HIV-therapy in pregnancy and in HIV-exposed newborn - update 2005. Eur J Med Res 2006; 11: 359–376.
  16. 16  Naver L , Bohlin AB , Albert J et al. Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2007. Scand J Infect Dis 2008; 40: 451–461.
  17. 17 US Public Health Service Task Force. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. (Updated July 8 2008). Available at http://aidsinfo.nih.gov/contentfiles/PerinatalGL.pdf (accessed 9 July 2009).
  18. Eramova, HIV/AIDS Treatment and Care. Clinical Protocols for the WHO European Region (2007)
  19. 19 British HIV Association. British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med 2008; 9: 452–502.
  20. 20  Read JS , Newell MK. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. Cochrane Database Syst Rev 2005(4):CD005479.
  21. 21 European HIV Obstetrics Group. Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery. AIDS 2004; 18: 933–938.
  22. 22  Suy A , Hernandez S , Thorne C , Lonca M , Lopez M , Coll O. Current guidelines on management of HIV-infected pregnant women: impact on mode of delivery. Eur J Obstet Gynecol Reprod Biol 2008; 139: 127–132.
  23. 23 European Collaborative Study. Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. Clin Infect Dis 2007; 44: 1647–1656.
  24. 24  Clarke SM , Mulcahy F , Healy CM , Condon S , Butler KM. The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome. Int J STD AIDS 2000; 11: 220–223.
  25. 25  Morris AB , Cu-Uvin S , Harwell JI et al. Multicenter review of protease inhibitors in 89 pregnancies. J Acquir Immune Defic Syndr 2000; 25: 306–311.
  26. 26  McGowan JP , Crane M , Wiznia AA , Blum S. Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women. Obstet Gynecol 1999; 94: 641–646.
  27. 27  Cooper ER , Charurat M , Burns DN , Blattner W , Hoff R. Trends in antiretroviral therapy and mother-infant transmission of HIV. The Women and Infants Transmission Study Group. J Acquir Immune Defic Syndr 2000; 24: 45–47.
  28. 28  Borleffs JCC , Danner SA , Lange JMA , van Everdingen JJE , Orichtlijn CB. Antiretrovirale behandeling in Nederland. Ned Tijdschr Geneeskd 2001; 145: 1585–1589.
  29. 29  Townsend CL , Cortina-Borja M , Peckham CS , Tookey PA. Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990–2006. BJOG 2008; 115: 1078–1086.
  30. 30  Jourdain G , Mary JY , Coeur SL et al. Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand. J Infect Dis 2007; 196: 1629–1636.
  31. 31  Thorne C , Newell ML. Mother-to-child transmission of HIV infection and its prevention. Curr HIV Res 2003; 1: 447–462.
  32. 32  Kuhn L , Steketee RW , Weedon J et al. Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study. J Infect Dis 1999; 179: 52–58.
  33. 33  Thorne C , Patel D , Newell ML. Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 2004; 18: 2337–2339.
  34. 34  Townsend CL , Cortina-Borja M , Peckham CS , Tookey PA. Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS 2007; 21: 1019–1026.
  35. 35  Cotter AM , Garcia AG , Duthely ML , Luke B , O'Sullivan MJ. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis 2006; 193: 1195–1201.
  36. 36  Grosch-Woerner I , Puch K , Maier RF et al. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women. HIV Med 2008; 9: 6–13.
  37. 37  Schulte J , Dominguez K , Sukalac T , Bohannon B , Fowler MG. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: pediatric spectrum of HIV disease, 1989–2004. Pediatrics 2007; 119: e900–e906.
  38. 38  Townsend C , Cortina-Borja M , Tookey P. Premature delivery and mother to child HIV transmission: risk:benefit analysis of HAART in pregnancy. In. Conference on Retroviruses and Opportunistic Infections, Montreal, February 8–11 2009; abstract 927. Available at http://www.retroconference.org/2009/Abstracts/34802.htm (accessed 25 August 2009).
  39. 39  Semprini AE , Castagna C , Ravizza M et al. The incidence of complications after caesarean section in 156 HIV-positive women. AIDS 1995; 9: 913–917.
  40. 40  Stamilio DM , DeFranco E , Pare E et al. Short interpregnancy interval: risk of uterine rupture and complications of vaginal birth after cesarean delivery. Obstet Gynecol 2007; 110: 1075–1082.